Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes (NCT04770701) | Clinical Trial Compass
WithdrawnPhase 4
Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes
Stopped: The study was withdrawn before enrollment due to administrative and board approval constraints.
Vietnam0Started 2020-09-20
Plain-language summary
This is a plant-based medication used to increase the amount, protect, and reduce HIV's impact on T and B lymphocytes.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants have a decline in CD4 + T-lymphocytes is the hallmark of HIV-1 infection.
Characterized by rapid loss of resistance: AIDS
* Dermatitis, mouth ulcers, skin rash, itching, weight loss
* HCV (+), HBV (+), Tuberculosis (+)
Exclusion Criteria:
* Cancer under all form
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this trial has been withdrawn and is no longer recruiting, can you tell me if there are any similar active studies looking at protecting and improving CD4 cell counts in people with HIV-1 that I might be eligible for?
2This was a Phase 4 trial, which typically means the treatment being studied has already been approved — can you explain what that would mean for my access to the same treatment outside of a trial setting?
3The trial was focused on measuring CD4 cell counts as its main outcome — how does my current CD4 count factor into the treatment decisions you'd recommend for me right now?
4Since this study was withdrawn before completing, is there any published information about why it was stopped, and should that affect how I think about the approach it was testing?
5Given that this trial is no longer available, what standard-of-care options exist today for improving or protecting CD4 and B cell levels in someone with my diagnosis?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.